Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses on developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. The company’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Medigen Biotechnology Corp - Key Facts
- Medigen Biotechnology Corp - Key Employees
- Medigen Biotechnology Corp - Key Employee Biographies
- Medigen Biotechnology Corp - Major Products and Services
- Medigen Biotechnology Corp - History
- Medigen Biotechnology Corp - Company Statement
- Medigen Biotechnology Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Medigen Biotechnology Corp - Business Description
- Medigen Biotechnology Corp - SWOT Analysis
- SWOT Analysis - Overview
- Medigen Biotechnology Corp - Strengths
- Medigen Biotechnology Corp - Weaknesses
- Medigen Biotechnology Corp - Opportunities
- Medigen Biotechnology Corp - Threats
- Medigen Biotechnology Corp - Key Competitors
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Medigen Biotechnology Corp, Recent Deals Summary
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Medigen Biotechnology Corp, Key Facts
- Medigen Biotechnology Corp, Key Employees
- Medigen Biotechnology Corp, Key Employee Biographies
- Medigen Biotechnology Corp, Major Products and Services
- Medigen Biotechnology Corp, History
- Medigen Biotechnology Corp, Other Locations
- Medigen Biotechnology Corp, Subsidiaries
- Medigen Biotechnology Corp, Key Competitors
- Medigen Biotechnology Corp, Annual Ratios
- Medigen Biotechnology Corp, Interim Ratios
- Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Medigen Biotechnology Corp, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Medigen Biotechnology Corp, Performance Chart (2017 - 2021)
- Medigen Biotechnology Corp, Ratio Charts
- Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- DR. Chip Biotech Inc
- Vita Genomics Inc
- Development Center for Biotechnology
- PhytoHealth Corp
- Lumosa Therapeutics Co Ltd
